Long-Lasting, Patient-Controlled, Procedure-Free Contraception: A Review of Annovera with a Pharmacist Perspective

Authors

Jennifer J. Virro, TherapeuticsMDFollow
Kathleen Besinque, besinque@chapman.eduFollow
Christiane E. Carney, TherapeuticsMDFollow
Danielle Gross, TherapeuticsMDFollow
Brian Bernick, TherapeuticsMDFollow
Sebastian Mirkin, TherapeuticsMDFollow

Document Type

Article

Publication Date

8-28-2020

Abstract

Annovera (segesterone acetate and ethinyl estradiol vaginal system) is a US Food and Drug Administration FDA-approved long-lasting, reversible contraceptive that is fully administered by the user and does not require a procedure for insertion or removal. The vaginal system is in the shape of a ring and contains low doses of a novel progestin, egesterone acetate, and ethinyl estradiol. It is made of silicone and is fully pliable and flexible. The vaginal system is reusable for 13 cycles, using a 21 days in/7 days out regimen, providing women with the ability to control their fertility. Particularly now during the COVID-19 pandemic when access to contraception has been further reduced, patients may benefit from a method that is both long-lasting and patient-controlled.

Comments

This article was originally published in Pharmacy, volume 8, issue 3, in 2020. https://doi.org/10.3390/pharmacy8030156

This scholarship is part of the Chapman University COVID-19 Archives.

Recommended Citation

Virro JJ, Besinque K, Carney CE, Gross D, Bernick B, Mirkin S. Long-Lasting, Patient-Controlled, Procedure-Free Contraception: A Review of Annovera with a Pharmacist Perspective. Pharmacy. 2020; 8(3):156. https://doi.org/10.3390/pharmacy8030156

Copyright

The authors

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.